Recent Posts
Archives
Learn more about HaemaLogix’s ground-breaking KappaMab technology
![shutterstock_731491177](https://www.irdepartment.com.au/site/irmblogpropertyfile/343/shutterstock_731491177.jpeg)
KappaMab is a monoclonal antibody developed by HaemaLogiX to treat blood cancers, with an initial focus on multiple myeloma.
KappaMab is a monoclonal antibody developed by HaemaLogiX to treat blood cancers, with an initial focus on multiple myeloma.